
Bioelements and Celluma partnered to educate estheticians on integrating LED light therapy into customized facial treatments for acne and aging skin.
San Francisco -- Patients with moderate to severe psoriasis can receive efalizumab (Anti-CD11a) continually with no increased toxicity for approximately one year, an ongoing open-label trial shows.






